Publication:

A review on SARS-CoV2 drug regimens inferring plausible mechanisms to impede the viral propagation and cytokine storm

A sharp outbreak of pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) in early 2020, has shaken up the whole global health care system and economy with its rapid chain-of-infection and high mortality index. This article emphasizes on the immunopathology of virus and current drug therapies. We have put down a compendious postulation on different drug actions vis-à-vis their reversing strategies for the pertinent diseases. A critical analysis has been made on the cytokine storm and focusing on to the interplays among lymphocytes and other innate immune cells (NK cells, macrophages, dendritic cells etc.) with secreted cytokines as well as on to the drug effectiveness by tallying with the contexts of SARS-CoV and Middle East respiratory syndrome coronavirus infections. The hustle and bustle is ongoing for repurposing existing drugs, designed for other infectious microbes. Tackling the adversities in anti-viral treatment has become too challenging to stop this contagion. Thereafter, the scientific front liners are on trials of hundreds of drugs by making comparisons to other contagious epidemics. Current review summarizes different drug actions on viral propagation and host immunomodulation. Our conjecture will intrigue to re-evaluate the mostly used drugs at present state.